Novo Nordisk’s owner backs an Italian fund to grow drug startups beyond Denmark

Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The move extends a pattern that has seen the Danish investor push capital into life sciences hubs well outsi

Related Stories

Farage-Backed Bitcoin Firm Suffers Devastating 15% Asset Value Slump

📰

Microsoft's new Azure Linux 4.0 is here, and it could replace Windows Server in the enterprise

Nvidia offers AI startups compute now, payment later

Indian Startup Alva Industries Lands €16M for Ultra-Compact Electric Motor Push